Skip to main content

Table 1 Characteristics and demographics of immunological responders and non-responders.

From: Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study

Characteristics

Immunologic responders

Immunologic non-responders

P

 

N = 236

N = 55

 

Male gender

179 (75.8)

48 (87.3)

0.065

Age at time of index date, median (IQR), years

37.6 (32.1 - 45.3)

42.6 (36.1 - 51.3)

<0.001

Caucasians

171 (72.5)

47 (85.5)

0.045

Route of HIV infection

  

0.059

   Men who have sex with men

97 (41.1)

29 (52.7)

 

   Heterosexually infected

98 (41.5)

14 (25.5)

 

   Injection drug user

14 (5.9)

7 (12.7)

 

   Other

26 (11.8)

3 (6.1)

 

Chronic HCV infection

20 (8.5)

8 (14.5)

0.169

Cancer within 13 years prior to index date

27 (11.4)

10 (18.2)

0.177

One or more AIDS defining events prior to index date

114 (48.3)

24 (43.6)

0.532

One or more AIDS defining events after index date

3 (1.3)

2 (3.6)

0.240

Diagnosed with HIV before 1 January 1995

94 (49.8)

27 (49.1)

0.210

Treated with zidofovir prior to index date

219 (92.8)

54 (98.2)

0.465

Nadir CD4 cell count, median (IQR), cells/μL

40 (10 - 82)

40 (15 - 57)

0.289

More than one year from first CD4 cell count ≤ 200 cells/μL to start of the virologically suppressed period*

96 (40.7)

32 (58.2)

0.019

Time from start of HAART to start of the virologically suppressed period, median (IQR), years

0.4 (0.2 - 1.1)

0.4 (0.3 - 1.3)

0.518

  1. * Median time from first CD4 cell count ≤ 200 cells/μL to start of the virologically suppressed period was 0.7 year (IQR; 0.3 - 2.2) for IRs and 1.5 years (IQR; 0.4 - 3.2) for INRs.